Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases
- PMID: 20162632
- PMCID: PMC2914827
- DOI: 10.1002/pds.1867
Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases
Abstract
Purpose: Mandated post-marketing drug safety studies require vast databases pooled from multiple administrative data sources which can contain private and proprietary information. We sought to create a method to conduct pooled analyses while keeping information private and allowing for full confounder adjustment.
Methods: We propose a method based on propensity score (PS) techniques. A set of propensity scores are computed in each data-contributing center and a PS-adjusted analysis is then carried out on a pooled basis. The method is demonstrated in a study of the potentially negative effects of concurrent initiation of clopidogrel and proton pump inhibitors (PPIs) in four cohorts of patients assembled from North American claims data sources. Clinical outcomes were myocardial infarction (MI) hospitalization and hospitalization for revascularization procedure. Success of the method was indicated by equivalent performance of our PS-based method and traditional confounder adjustment. We also implemented and evaluated high-dimensional propensity scores and meta-analytic techniques.
Results: On both a pooled and individual cohort basis, we saw substantially similar point estimates and confidence intervals for studies adjusted by covariates and from privacy-maintaining propensity scores. The pooled, adjusted OR for MI hospitalization was 1.20 (95% confidence interval 1.03, 1.41) with individual variable adjustment and 1.16 (1.00, 1.36) with PS adjustment. The revascularization OR estimates differed by < 1%. Meta-analysis and pooling yielded substantially similar results.
Conclusions: We observed little difference in point estimates when we employed standard techniques or the proposed privacy-maintaining pooling method. We would recommend the technique in instances where multi-center studies require both privacy and multivariate adjustment.
2010 John Wiley & Sons, Ltd.
Conflict of interest statement
No conflict of interest is found in this paper.
Figures
Similar articles
-
[Proton pump inhibitors: anti-ulcer agents or platelet aggregation inhibitors? Caution regarding drug interactions].Perspect Infirm. 2010 May-Jun;7(3):40. Perspect Infirm. 2010. PMID: 21744587 French. No abstract available.
-
Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.Ann Intern Med. 2010 Mar 16;152(6):337-45. doi: 10.7326/0003-4819-152-6-201003160-00003. Ann Intern Med. 2010. PMID: 20231564 Free PMC article.
-
Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome.Circulation. 2009 Dec 8;120(23):2322-9. doi: 10.1161/CIRCULATIONAHA.109.873497. Epub 2009 Nov 23. Circulation. 2009. PMID: 19933932 Free PMC article.
-
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.Lancet. 2009 Sep 19;374(9694):989-997. doi: 10.1016/S0140-6736(09)61525-7. Epub 2009 Aug 31. Lancet. 2009. PMID: 19726078 Review.
-
Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.J Cardiovasc Pharmacol Ther. 2010 Dec;15(4):326-37. doi: 10.1177/1074248410369109. Epub 2010 Oct 11. J Cardiovasc Pharmacol Ther. 2010. PMID: 20938037 Review.
Cited by
-
A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment.Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):619-27. doi: 10.1002/pds.3616. Epub 2014 Apr 30. Pharmacoepidemiol Drug Saf. 2014. PMID: 24788694 Free PMC article.
-
Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study.Alzheimers Dement (N Y). 2020 Nov 26;6(1):e12095. doi: 10.1002/trc2.12095. eCollection 2020. Alzheimers Dement (N Y). 2020. PMID: 33304987 Free PMC article.
-
Effect Estimation in Point-Exposure Studies with Binary Outcomes and High-Dimensional Covariate Data - A Comparison of Targeted Maximum Likelihood Estimation and Inverse Probability of Treatment Weighting.Int J Biostat. 2016 Nov 1;12(2):/j/ijb.2016.12.issue-2/ijb-2015-0034/ijb-2015-0034.xml. doi: 10.1515/ijb-2015-0034. Int J Biostat. 2016. PMID: 27889705 Free PMC article.
-
Stakeholders' views on data sharing in multicenter studies.J Comp Eff Res. 2017 Sep;6(6):537-547. doi: 10.2217/cer-2017-0009. Epub 2017 Aug 14. J Comp Eff Res. 2017. PMID: 28805448 Free PMC article.
-
Combining distributed regression and propensity scores: a doubly privacy-protecting analytic method for multicenter research.Clin Epidemiol. 2018 Nov 27;10:1773-1786. doi: 10.2147/CLEP.S178163. eCollection 2018. Clin Epidemiol. 2018. PMID: 30568510 Free PMC article.
References
-
- Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol. 1999;28(1):1–9. - PubMed
-
- Friedenreich CM. Methods for pooled analyses of epidemiologic studies. Epidemiology. 1993;4(4):295–302. - PubMed
-
- Smith-Warner SA, Spiegelman D, Ritz J, et al. Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol. 2006;163(11):1053–1064. - PubMed
-
- Maro JC, Platt R, Holmes JH, et al. Design of a National Distributed Health Data Network. Ann Intern Med. 2009;151(5):341–4. - PubMed
-
- Lieu TA, Kulldorff M, Davis RL, et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care. 2007;45(10 Supl 2):S89–S95. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources